Breaking News

A CAR-T crisis has patients dying on a waitlist

  

 

Weekend Reads

‘How do you decide?’: Cancer therapy's CAR-T crisis has patients dying on a waitlist

By Angus Chen

MD Anderson Cancer Center

Within two years of being diagnosed with multiple myeloma, Shawn Goltzene (above) had blasted through nearly all his options. His clinician saw only one possibility left to save his life — a newly approved CAR-T cell therapy. But the shortage of CAR-T therapy for multiple myeloma is creating a gut-wrenching dilemma for clinicians: Doctors must decide which of their dozens of eligible patients will get one of a few coveted CAR-T spots each month.

Read More

More great reads from STAT this week

Saturday, June 4, 2022

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2022, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments